Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-Acting Injection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05418868
What this trial is testing

Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 214
Large-scale testing (Phase 3)Study completedNCT00297388
What this trial is testing

How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Large-scale testing (Phase 3)Study completedNCT00236548
What this trial is testing

Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1
Not applicableLooking for participantsNCT07370649
What this trial is testing

Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

Who this might be right for
Human Immunodeficiency Virus (HIV)-1 InfectionHIV-1 Subtype A6 InfectionHIV-1 Subtype B Infection+1 more
Pomeranian Medical University Szczecin 250
Early research (Phase 1)Study completedNCT01377610
What this trial is testing

Improved Strategies for Outpatient Opioid Detoxification

Who this might be right for
Opioid Dependence
New York State Psychiatric Institute 150
Large-scale testing (Phase 3)Study completedNCT00225979
What this trial is testing

Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT00495118
What this trial is testing

A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 314
Early research (Phase 1)Study completedNCT07799090
What this trial is testing

Pharmacokinetic Study of GB-5001A 280 mg Long Acting Injection, in Comparison With the Comparator Drug Aricept® 5 mg and Aricept® 10 mg Film-coated Tablet in Healthy Subjects

Who this might be right for
Bioavailability Study on Healthy Volunteers
G2GBio, Inc. 28
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Testing effectiveness (Phase 2)Study completedNCT02120352
What this trial is testing

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 309
Post-approval studies (Phase 4)Active Not RecruitingNCT05986084
What this trial is testing

Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

Who this might be right for
Pre-Exposure Prophylaxis (PrEP)Breast Feeding
Beth Israel Deaconess Medical Center 500
Testing effectiveness (Phase 2)WithdrawnNCT01272258
What this trial is testing

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

Who this might be right for
HIV
CytoDyn, Inc.
Not applicableNot Yet RecruitingNCT07346508
What this trial is testing

Project SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A Nurse-driven Protocol

Who this might be right for
HIV (Human Immunodeficiency Virus)
KC Care Health Center 250
Not applicableStudy completedNCT01181960
What this trial is testing

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

Who this might be right for
SchizophreniaBipolar Disorder
Janssen Scientific Affairs, LLC 1,066
Large-scale testing (Phase 3)Study completedNCT00249223
What this trial is testing

A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen Pharmaceutica N.V., Belgium 641
Not applicableNot Yet RecruitingNCT05835635
What this trial is testing

Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine

Who this might be right for
Patient SatisfactionPatient PreferenceQuality of Life+1 more
Pontificia Universidad Catolica de Chile 50
Large-scale testing (Phase 3)Study completedNCT00132314
What this trial is testing

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Who this might be right for
Schizoaffective DisorderSchizophrenia
US Department of Veterans Affairs 382
Large-scale testing (Phase 3)Study completedNCT00034775
What this trial is testing

Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141
Large-scale testing (Phase 3)Looking for participantsNCT06961968
What this trial is testing

Randomized Withdrawal Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 400
Large-scale testing (Phase 3)Active Not RecruitingNCT06694805
What this trial is testing

Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 326
Next Page